These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 25975105)
41. [Correction of central nervous system energy processes in children with the minimal cerebral dysfunction]. Lavrik SIu; Domitrak SV; Shprakh VV Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(4):37-41. PubMed ID: 21512499 [TBL] [Abstract][Full Text] [Related]
42. Evaluation of the Protective Effect of Ademetionine, Cytoflavin, and Dihydroquercetetine on Blood Enzymes Activity in Rats Treated with High Doses of Sodium Valproate. Okhremchuk LV; Seminskii IZ; Darenskaya MA; Grebenkina LA; Kolesnikova LI; Kolesnikov SI Bull Exp Biol Med; 2020 Dec; 170(2):211-214. PubMed ID: 33263851 [TBL] [Abstract][Full Text] [Related]
43. [Efficacy of cytoflavin in patients in the acute ischemic stroke]. Odinak MM; Skvortsova VI; Vozniuk IA; Rumiantseva SA; Stakhovskaia LV; Klocheva EG; Novikova LB; Ianishevskiĭ SN; Golokhvastov SIu; Tsygan NV Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):29-36. PubMed ID: 21311484 [TBL] [Abstract][Full Text] [Related]
44. [Influence of cytoflavin on symptoms of asthenia, emotional disorders and autonomic regulation in patients with organic asthenic disorder]. Polunina AG; Osinovskaia NA; Gudkova AN; Gekht AB Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(2):28-33. PubMed ID: 24662341 [TBL] [Abstract][Full Text] [Related]
45. [Performance evaluation of integrated cytoprotective therapy of different duration in patients with cerebral infarction]. Chichanovskaia LV; Tsukurova LA; Kovalenko AL; Nazarov MV; Lukin DI; Rumiantseva SA; Silina EV; Stupin VA; Nedorostkova TIu; Kabaeva EN; Eliseev EV Eksp Klin Farmakol; 2015; 78(1):21-6. PubMed ID: 25826870 [TBL] [Abstract][Full Text] [Related]
46. [Efficacy of the complex drug cytoflavin in the treatment of consequences of mild brain injury]. Skoromets AA; Pugacheva EL Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3):31-6. PubMed ID: 20517223 [TBL] [Abstract][Full Text] [Related]
47. [THE INFLUENCE OF CYTOFLAVIN AND CARDIOXIPIN ON THE PARAMETERS OF 24-HOUR ARTERIAL PRESSURE MONITORING IN PATIENTS WITH CHRONIC CEREBRAL CIRCULATION INSUFFICIENCY, ARTERIAL HYPERTENSION AND HYPERCHOLESTEROLEMIA]. Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV Klin Med (Mosk); 2015; 93(2):67-71. PubMed ID: 26117922 [TBL] [Abstract][Full Text] [Related]
48. [Effect of the Cytoflavin on the distal polyneuropathy severity in patients with diabetic foot syndrome with arteries mediacalcinosis]. Skripko VD; Kovalenko AL; Zaplutanov VA Khirurgiia (Mosk); 2017; (8):75-78. PubMed ID: 28805783 [TBL] [Abstract][Full Text] [Related]
49. [Investigation of the effects of cytoflavin on symptoms of depression and autonomic dysfunction in patients with organic depressive disorder]. Gudkova AN; Osinovskaia NA; Polunina AG; Gekht AB Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):50-5. PubMed ID: 24430035 [TBL] [Abstract][Full Text] [Related]
50. [Effects of cytoflavin on neuronal apoptotic processes in the murine cerebral cortex on a model of physiologicaland pathological aging]. Bazhanova ED; Sokolova YO; Teplyi DL Arkh Patol; 2019; 81(4):59-65. PubMed ID: 31407720 [TBL] [Abstract][Full Text] [Related]
51. [Investigation of markers for myocardial remodeling during experimental hypobaric hypoxia in the correction with cytoflavin]. Sataeva TP; Zadnipryany IV Arkh Patol; 2018; 80(6):35-42. PubMed ID: 30585591 [TBL] [Abstract][Full Text] [Related]
52. [Approaches to the improvement of treatment efficacy in patients with acute severe asaleptin intoxication complicated by acute respiratory insufficiency of mixed genesis]. Shilov VV; Andriaov AY; Loladze AT; Batotsyrenov BV Klin Med (Mosk); 2012; 90(10):24-7. PubMed ID: 23285757 [TBL] [Abstract][Full Text] [Related]
53. [Modern methods of energy homeostasis correction in elderly patients]. Rumiantseva SA; Silina EV; Tsukurova LA; Stupin VA; Chichanovskaia LV; Nazarov MV; Kovalenko AL; Kabaeva EN Adv Gerontol; 2014; 27(4):746-52. PubMed ID: 25946854 [TBL] [Abstract][Full Text] [Related]
54. [Efficacy of cytoflavin in the treatment of chronic cerebral ischemia]. Suslina ZA; Klocheva EG; Piradov MA; Rumiantseva SA; Romantsov MG; Kovalenko AL Klin Med (Mosk); 2010; 88(3):50-3. PubMed ID: 20608066 [TBL] [Abstract][Full Text] [Related]
55. [Clinical effectiveness of cytoflavin inclusion in intensive care of patients with combined traumatic brain injury]. Lebedeva EA; Kurtasov AA; Belousova ME; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL Eksp Klin Farmakol; 2014; 77(4):42-4. PubMed ID: 25076759 [TBL] [Abstract][Full Text] [Related]
56. [Treatment of alcohol addiction syndrome with cytoflavin]. Belov VG; Parfenov IuA; Okovityĭ SV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6 Pt 2):54-7. PubMed ID: 23887469 [TBL] [Abstract][Full Text] [Related]
57. [Improvement of speech discrimination with cytoflavin in patients with chronic sensorineural deafness]. Zhuravskiĭ SG Vestn Otorinolaringol; 2010; (4):82-6. PubMed ID: 21105353 [No Abstract] [Full Text] [Related]
58. [Effect of cytoflavine on bioenergetic processes in the liver after severe limb compression trauma]. Iunusov IA; Zarubina IV Eksp Klin Farmakol; 2009; 72(6):42-5. PubMed ID: 20095400 [TBL] [Abstract][Full Text] [Related]
59. [Energy corrective and antioxidative actions of cytoflavin during postischemic period of human dermal fibroblasts in vitro]. Tiuriaeva II; Kuranova ML; Gonchar IV; Rozanov IuM Tsitologiia; 2012; 54(6):489-96. PubMed ID: 22997734 [TBL] [Abstract][Full Text] [Related]